Tender ID

Kerala

Technical Eval

Goods

Medicines

Re-tender for the procurement of Anti Haemophilia Drugs for the year 2025-26

Kerala Medical Services Corporation Ltd

Thiruvananthapuram, Kerala

Amount: Refer DocsCloses: 7 Mar 2026Closed

Timeline

Published23 Feb 2026
Closed7 Mar 2026
Technical Evaluation7 May 2026
Award—

Bids

2 Bids7 May 2026

#	Company	Status
1	Grifols India Healthcare Private Limited Accepted-Technical	Accepted-Technical Details in notice
2	TAKEDA BIOPHARMACEUTICALS INDIA PRIVATE LIMITED Accepted-Technical 6TH FLOOR BUILDING NO 8 TOWER C DLF CYBER CITY PHASE II MOTI NAGAR GURGAON WEST DELHI DELHI 122002 \| GURUGRAM \| HARYANA \| 122002	Accepted-Technical Details in notice

Tender Value

Refer Docs

EMD Value

₹23,200

Closing Date

7 Mar 2026, 5:00 pmClosed

Tender Inviting Organisation

Name

Managing Director

Address

KMSCL, Thycaud

Work Description

Re-tender for the procurement of Anti Haemophilia Drugs for the year 2025-26

Tender Information

Tender ID

2026_KMSCL_839492_1

Reference Number

KMSCL/ED/HAEM/RT/2026/005

Tender Type

Open Tender

Product Category

Medicines

Form of Contract

Item Rate

Period of Work

365 days

Location

Thiruvananthapuram

Source Website

Subscribe to view

Eligibility / Pre-Qualification

Please refer tender document

Documents Required

31 documents required · 31 mandatory

Fee/PreQual/Technical

RequiredCheck list in Anx 1 (.pdf)

RequiredThe details of the online EMD submitted as per sl no 2 of Anx 1 (.pdf)

RequiredThe details of Re-inspection fee as per sl no 3 of Anx 1 (.pdf)

RequiredThe details of factory inspection fee as per sl no 4 of Anx 1 (.pdf)

RequiredBid offer form as per sl no 5 of Anx 1 (.pdf)

RequiredBid offer form as per sl no 6 of Anx 1 (.xls)

RequiredNotary attested copy of Average Annual turnover stmt as per sl no 7 of Anx 1 (.pdf)

Requirednotary attested photocopy of original manufacturing license as per sl no 8 of Anx 1 (.pdf)

RequiredNotary attested copy of import license as per ls no 9 of Anx 1 (.pdf)

RequiredNotary attested copy of product wise market standing certiificate as per sl no 10 of Anx 1 (.pdf)

Requirednotary attested copy of valid license as per sl no 11 of Anx 1 (.pdf)

RequiredNotary attested copy of WHO GMP certificate as per sl no 12 of Anx 1 (.pdf)

RequiredNotary attested copy of valid COPP issued by the Licensing Authority as per the sl no 13 of Anx 1 (.pdf)

RequiredNotary attested copy of stmt of method as per sl no 15 of Anx 1 (.pdf)

RequiredNotary attested copy of relevant documents on viral inactivation as per sl no 14 of Anx 1 (.pdf)

RequiredNotary attested copy of relevant documents on viral detection tests as per sl no 16 of Anx 1 (.pdf)

RequiredNotary attested copy of stmt on the viral detection as per ls no 17 of Anx 1 (.pdf)

RequiredNotary attested copy of relevant documents to prove the purity as per ls no 18 of Anx 1 (.pdf)

Requirednotary attetsed copy of stmt on purity of the offered products as per ls no 19 of Anx 1 (.pdf)

RequiredNotary attested relevant documents on donor traceability as per ls no 20 of Anx 1 (.pdf)

RequiredNotary attested copy of details of batches tested in NIB as per sl no 21 of Anx 1 (.pdf)

RequiredNotary attested copy of stmt as per sl no 22 of Anx1 (.pdf)

RequiredNotary attested documents to prove the supply of quoted items as per sl no 23 of Anx 1 (.pdf)

RequiredNotary attested copy of current Non conviction certificate as per sl no 24 of Anx 1 (.pdf)

RequiredNotary attested stmt of manufacture as per sl no 25 of Anx 1 (.pdf)

RequiredNotary attested copy of PoA as per ls no 26 of Anx 1 (.pdf)

RequiredNotary attested copy of undertaking as per sl no 27 of Anx 1 (.pdf)

RequiredNotary attested copy of Audited Balance sheets and P and L stmt as per sl no 28 of Anx 1 (.pdf)

RequiredNotary attested details of technical personnel as per sl no 29 of Anx 1 (.pdf)

RequiredNotary attested details of the bidder as per sl no 30 of Anx 1 (.pdf)

Finance

RequiredPrice bid format (.xls)

Fee & Financial Details

Tender Fee Amount

₹4,150

Tender Fee Exemption Allowed

Yes

EMD Fee Amount

₹23,200

EMD Fee Exemption Allowed

Yes

Important Dates

Last Activity

7 May 2026

Published

23 Feb 2026

Bid Opening

9 Mar 2026

Download Starts

23 Feb 2026

Download Ends

7 Mar 2026

Submission Starts

23 Feb 2026

Clarification Period

23 Feb 2026 - 7 Mar 2026

Bill of Quantities

Item WiseBoQ_Ver3.0INR

BoQ1 (1 items)

Sl No	Description	Qty	Unit	Est. Rate	Est. Amount
1	ANTI HAEMOPHILIC FACTOR VIII with VON WILLEBRAND FACTOR 250 IU (contains Factor VIII 250 IU along with minimum 50% of VWF)	1,700	1 No	5	₹8,500

Stage Documents

Stage Summary Snapshot

stage.html

html • 0.02 MB

Technical Evaluation

tech_eval.pdf

PDF

Documents

Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.

Tender Page Snapshot

details.html

html • 0.04 MB

NIT Documents

Tendernotice_1.pdf

PDF • 0.36 MB

Work Item Documents

HAEM.pdf

Tender Documents • 2.07 MB

BOQ_1414702.xls

BOQ • 0.23 MB

Ready to Participate?

Download all tender documents and submit your bid

Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .

Loading…

Company

Grifols India Healthcare Private Limited

Accepted-Technical

TAKEDA BIOPHARMACEUTICALS INDIA PRIVATE LIMITED

Accepted-Technical

6TH FLOOR BUILDING NO 8 TOWER C DLF CYBER CITY PHASE II MOTI NAGAR GURGAON WEST DELHI DELHI 122002 | GURUGRAM | HARYANA | 122002

Sl No

Description

Qty

Unit

Est. Rate

Est. Amount

ANTI HAEMOPHILIC FACTOR VIII with VON WILLEBRAND FACTOR 250 IU (contains Factor VIII 250 IU along with minimum 50% of VWF)

1,700

1 No

₹8,500